OFA patients with no prior DMT treatment trended toward higher total spike and spike RBD IgG levels compared to OFA patients who transitioned from other anti-CD20 mAb or S1P DMTs, but this did not reach statistical significance (Supplemental Fig. 3).
← all excerpts
Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators.
1
—
—